Two US suppliers have joined together to use a patented technology to bring a range of powers to market that had previously only been available in oil form.
Danish biotech firm Fluxome is preparing to launch a yeast-fermented resveratrol in the US market, which it claims will deliver a consistent high quality and purity ingredient at a commercially viable price.
Probiotic chews are being rolled out by manufacturers looking for varied ways of encouraging consumers to introduce ‘friendly bacteria’ into their diet.